# Immunovant, Inc.: Form DEF 14A, filed Jul 22, 2026

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: DEF 14A
- Filed: 2026-07-22
- Accepted by EDGAR: Jul 22, 2026, 16:10 ET
- Period: 2026-09-02
- Accession: 0001764013-26-000092
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401326000092/imvt-20260721.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401326000092/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401326000092/imvt-20260721.htm

Filed Jul 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001764013-26-000092. Last ingested by Listed: Nov 9, 2026, 17:43 ET. No prices; not investment advice.